Statins and the Acute-Phase Response
- 28 June 2001
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 344 (26) , 2016-2018
- https://doi.org/10.1056/nejm200106283442609
Abstract
C-reactive protein is the classic acute-phase reactant. During severe infection or inflammation, blood concentrations of C-reactive protein may increase by a factor of 500 or more. Although most other acute-phase reactants are not as dynamic or as easily measured, they and C-reactive protein may make important contributions to the body's responses to injury, infection, and other sources of stress.Many acute-phase proteins are thought to be antiinfective. C-reactive protein binds to phosphocholine on the surfaces of invading microbes and marks them for killing by complement and phagocytes, whereas secretory phospholipase A2 is a potent antistaphylococcal and antistreptococcal enzyme. Acute-phase . . .Keywords
This publication has 15 references indexed in Scilit:
- Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary EventsNew England Journal of Medicine, 2001
- C-reactive protein elevation can be caused by conditions other than inflammation and may reflect biologic aging.Cleveland Clinic Journal of Medicine, 2001
- Normal Responses to Injury Prevent Systemic Inflammation and Can Be ImmunosuppressiveAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Simvastatin Has Anti-Inflammatory and Antiatherosclerotic Activities Independent of Plasma Cholesterol LoweringArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Infection and Inflammation‐Induced Proatherogenic Changes of LipoproteinsThe Journal of Infectious Diseases, 2000
- Expression of Angiotensin II and Interleukin 6 in Human Coronary Atherosclerotic PlaquesCirculation, 2000
- C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in WomenNew England Journal of Medicine, 2000
- Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftinessDiabetologia, 1999
- Fibrinogen and coronary riskCurrent Cardiology Reports, 1999
- IL-6 and APPs: anti-inflammatory and immunosuppressive mediatorsImmunology Today, 1997